Andrew E. Mulberg

Pediatric Gastroenterology

3 Cooper Plz
Camden, NJ 08103

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Approval for Children With Inflammatory Bowel Disease.

An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Approval for Children With Inflammatory Bowel Disease.

Journal: Inflammatory bowel diseases

Published: August 11, 2024

Correction to: Sharing is caring: a call for a new era of rare disease research and development.

Correction to: Sharing is caring: a call for a new era of rare disease research and development.

Journal: Orphanet journal of rare diseases

Published: January 23, 2023

Reply.

Reply.

Journal: Gastroenterology

Published: July 31, 2022

Coefficient of Fat Absorption to Measure the Efficacy of Pancreatic Enzyme Replacement Therapy in People With Cystic Fibrosis: Gold Standard or Coal Standard?

Coefficient of Fat Absorption to Measure the Efficacy of Pancreatic Enzyme Replacement Therapy in People With Cystic Fibrosis: Gold Standard or Coal Standard?

Journal: Pancreas

Published: June 13, 2022

Regulatory and Clinical Expert Perspective of the 2022 FDA Draft Guidance "Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet".

Regulatory and Clinical Expert Perspective of the 2022 FDA Draft Guidance "Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet".

Journal: Gastroenterology

Published: May 05, 2022

Sharing is caring: a call for a new era of rare disease research and development.

Sharing is caring: a call for a new era of rare disease research and development.

Journal: Orphanet journal of rare diseases

Published: February 16, 2022

Pediatric Extrapolation of Adult Efficacy to Children Is Critical for Efficient and Successful Drug Development.

Pediatric Extrapolation of Adult Efficacy to Children Is Critical for Efficient and Successful Drug Development.

Journal: Gastroenterology

Published: January 19, 2022

FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument.

FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: April 12, 2021

Data silos are undermining drug development and failing rare disease patients.

Data silos are undermining drug development and failing rare disease patients.

Journal: Orphanet journal of rare diseases

Published: February 05, 2021

Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severity.

Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severity.

Journal: Journal of patient-reported outcomes

Published: May 05, 2020

Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and Vomiting.

Extrapolation of Adult Efficacy to Pediatric Patients With Chemotherapy-Induced Nausea and Vomiting.

Journal: Journal of clinical pharmacology

Published: September 04, 2019

Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children.

Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children.

Journal: Current therapeutic research, clinical and experimental

Published: January 16, 2019

Showing 1-12 of 39

Last Updated: 09/26/2026